Kezar Life Sciences Inc (KZR)
7.55
+0.01
(+0.13%)
USD |
NASDAQ |
Nov 14, 16:00
7.55
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Total Liabilities (Quarterly): 29.24M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 29.24M |
| March 31, 2024 | 30.01M |
| December 31, 2023 | 33.66M |
| September 30, 2023 | 33.33M |
| June 30, 2023 | 31.10M |
| March 31, 2023 | 31.69M |
| December 31, 2022 | 29.70M |
| September 30, 2022 | 21.58M |
| June 30, 2022 | 20.14M |
| March 31, 2022 | 19.55M |
| December 31, 2021 | 21.06M |
| September 30, 2021 | 11.41M |
| June 30, 2021 | 9.786M |
| March 31, 2021 | 11.70M |
| Date | Value |
|---|---|
| December 31, 2020 | 10.86M |
| September 30, 2020 | 10.89M |
| June 30, 2020 | 10.00M |
| March 31, 2020 | 11.99M |
| December 31, 2019 | 11.47M |
| September 30, 2019 | 11.03M |
| June 30, 2019 | 10.66M |
| March 31, 2019 | 10.91M |
| December 31, 2018 | 5.885M |
| September 30, 2018 | 6.14M |
| June 30, 2018 | 6.33M |
| March 31, 2018 | 6.809M |
| December 31, 2017 | 79.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.786M
Minimum
Jun 2021
33.66M
Maximum
Dec 2023
20.48M
Average
20.14M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
| Oragenics Inc | 1.383M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.92M |
| Shareholders Equity (Quarterly) | 150.68M |